A combination of N-803 with two anti-PD-L1 domains (N-809) was able to promote the cytotoxic function of CD8+ T cells and natural killer cells as well as bind to tumor cell PD-L1, synergistically increasing tumor cell lysis in vitro and in murine models [30,31]. Here, CD8A is linked to neoplasm.